← back to search

Wu Zhang

University of Southern California · US
Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Colorectal Cancer Treatments and Studies, Genetic factors in colorectal cancer, Lung Cancer Treatments and Mutations, and Cancer Genomics and Diagnostics.
h-index
48
citations
9,411
works
490
NIH funding
primary concept
Medicine
email

Recent publications

Delving into female breast cancer: Distinct disease-specific survival outcomes between invasive lobular and ductal carcinomas revealed by propensity score matching
PLoS ONE 2024cited by 0position: firstdoi
Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort study
The Lancet Oncology 2023cited by 83position: middledoi
Tissue factor expression in colorectal cancer.
Journal of Clinical Oncology 2023cited by 4position: middledoi
The Landscape of Alterations in DNA Damage Response Pathways in Colorectal Cancer
Clinical Cancer Research 2021cited by 41position: middledoi
Large-scale analysis of KMT2 mutations defines a distinctive molecular subset with treatment implication in gastric cancer
Oncogene 2021cited by 36position: middledoi
Molecular characteristics and clinical outcomes of patients with Neurofibromin 1-altered metastatic colorectal cancer
Oncogene 2021cited by 22position: middledoi
The impact of ARID1A mutation on molecular characteristics in colorectal cancer
European Journal of Cancer 2020cited by 75position: middledoi
A non-invasive monitoring of USPIO labeled silk fibroin/hydroxyapatite scaffold loaded DPSCs for dental pulp regeneration
Materials Science and Engineering C 2019cited by 27position: firstdoi
B cell and B cell-related pathways for novel cancer treatments
Cancer Treatment Reviews 2018cited by 262position: middledoi
CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy
Cancer Treatment Reviews 2017cited by 1,608position: middledoi
A <i>let-7</i> microRNA-Binding Site Polymorphism in <i>KRAS</i> Predicts Improved Outcome in Patients with Metastatic Colorectal Cancer Treated with Salvage Cetuximab/Panitumumab Monotherapy
Clinical Cancer Research 2014cited by 59position: middledoi
FCGR polymorphisms and cetuximab efficacy in chemorefractory metastatic colorectal cancer: an international consortium study
Gut 2014cited by 27position: middledoi
Prospective Validation of Candidate SNPs of VEGF/VEGFR Pathway in Metastatic Colorectal Cancer Patients Treated with First-Line FOLFIRI Plus Bevacizumab
PLoS ONE 2013cited by 75position: middledoi
Prospective evaluation of candidate SNPs of <i>VEGF/VEGFR</i> pathway in metastatic colorectal cancer (mCRC) patients (pts) treated with first-line FOLFIRI plus bevacizumab (BV).
Journal of Clinical Oncology 2012cited by 2position: middledoi

Grants

Intersection Theory and Height Pairings in Arithmetic Geometry
NSF2101787$277,9982021–2024PIRePORTER
Topics in Arithmetic Geometry: Moduli Varieties, L-functions, Arakelov Theory and Their Interactions and Applications
NSF1700883$193,1852017–2021PIRePORTER
Topics in arithmetic geometry
NSF1404369$227,9992014–2017PIRePORTER
Analysis, Spectra, and Number Theory
NSF1446181$50,0002014–2015PIRePORTER
FRG: Collaborative Research: Periods of Automorphic Forms and Applications to L- Functions
NSF1415502$183,8062013–2016PIRePORTER
FRG: Collaborative Research: Periods of Automorphic Forms and Applications to L- Functions
NSF1065839$286,2712011–2014PIRePORTER
Topics in arithmetic algebraic geometry
NSF0970100$300,0002010–2013PIRePORTER
Topics in arithmetic algebraic geometry
NSF0700322$255,0002007–2011PIRePORTER
L-Functions and Automorphic Forms
NSF0638902$40,0002006–2007PIRePORTER
Collaborative Research / FRG: Arakelov Theory and Modular Forms
NSF0354436$185,0002004–2008PIRePORTER
Topics in Arithmetic Algebraic Geometry
NSF0201691$513,2952002–2008PIRePORTER
Topics in Arithmetic Algebraic Geometry
NSF9820909$239,9991999–2002PIRePORTER
Mathematical Sciences: Arakelov Theory
NSF9796021$59,3741996–1999PIRePORTER
Mathematical Sciences: Arakelov Theory
NSF9623053$24,9001996–1997PIRePORTER

Frequent collaborators

Heinz‐Josef Lenz · Keck Hospital of USC10 papers (2012–2023)Shivani Soni · Caris Life Sciences (United States)7 papers (2017–2023)Francesca Battaglin · University of Southern California6 papers (2018–2023)W. Michael Korn · Itasca Community College5 papers (2020–2023)Hiroyuki Arai · University of Southern California4 papers (2020–2023)Joshua Millstein · USC Norris Comprehensive Cancer Center4 papers (2021–2023)John L. Marshall · Columbia University4 papers (2020–2023)Joanne Xiu · Enzo Life Sciences (United States)4 papers (2020–2023)Richard M. Goldberg · West Virginia University Hospitals4 papers (2020–2023)Alberto Puccini · Humanitas University3 papers (2017–2020)Ryuma Tokunaga · Kumamoto University3 papers (2017–2020)Benjamin A. Weinberg · Caris Life Sciences (United States)3 papers (2021–2023)Emil Lou · University of Minnesota3 papers (2021–2023)Martin D. Berger · Technische Universität Dresden3 papers (2017–2020)Madiha Naseem · University of Queensland3 papers (2017–2020)Anthony F. Shields · The Barbara Ann Karmanos Cancer Institute3 papers (2020–2023)Chiara Cremolini · Istituti di Ricovero e Cura a Carattere Scientifico3 papers (2012–2021)Natsuko Kawanishi · University of Southern California3 papers (2021–2023)Dongyun Yang · City Of Hope National Medical Center3 papers (2012–2014)Hideo Baba · Kumamoto Health Science University3 papers (2017–2020)